PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Barbara Melosky, MD, FRCPC - Navigating Recent Updates With Immunotherapy for Advanced NSCLC: Guidance to Optimize Treatment Decisions
Visit https://www.peervoice.com/BCD860 to view the entire programme with slides. After completing “Barbara Melosky, MD, FRCPC - Navigating Recent Updates With Immunotherapy for Advanced NSCLC: Guidance to Optimize Treatment Decisions”, participants will be able to: Discuss the latest clinical evidence with chemo-immunotherapy regimens for the treatment of advanced non-small cell lung cancer (NSCLC); and Evaluate how these data may inform treatment selection in patients with advanced NSCLC in the Canadian landscape.